Managing Partner
Tom is a co-founder of Keelin Reeds Partners. In the last three years, he has supervised portfolio management, asset strategy and valuation, or deal terms assessment and negotiations projects for more than 30 emerging biotechs. To support emerging-biotech decisions about when to partner and under what terms, he supervised a joint effort between Keelin Reeds Partners and the Biotechnology Industry Organization (BIO) to develop, benchmark, and validate a way to estimate asset-specific deal terms based on the asset-specific economic characteristics and relative strength of negotiating position of the parties. In parallel, he invented, tested, and authored a patent application on an innovative R&D productivity simulation method which uniquely highlights improved portfolio management approaches that may more than double R&D productivity for some companies. Previously, he led business and product strategy efforts for dozens of Global 1000 companies. He also pioneered and helped them implement their adopted methods for asset valuation and portfolio management. He is a co-author of the Harvard Business Review article "How SmithKline Beecham Makes Better Resource Allocation Decisions" (Mar-Apr '98), founder of the life sciences practice within Strategic Decisions Group (SDG) and served as SDG's Worldwide Managing Director and head of its strategy and strategy implementation consulting practices. Tom has testified before legislative or regulatory bodies in California, Illinois, Indiana, New York, Wisconsin, and Ontario (Canada) on issues of decision quality, investment risk analysis under uncertainty, prudence, usefulness, and customer markets.Tom also serves on the Board of Directors and Executive Committee of the Decision Education Foundation, a not-for-profit organization he co-founded which focuses on helping youth learn good decision-making as a life skill. Tom holds three degrees from Stanford University: BA in economics and MS and PhD in Engineering-Economic Systems.
